Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Directed phenotype switching as an effective antimelanoma strategy.

Journal article

Sáez-Ayala M. et al, (2013), Cancer Cell, 24, 105 - 119

A phase I study of oral rucaparib in combination with carboplatin.

Journal article

Molife LR. et al, (2013), JOURNAL OF CLINICAL ONCOLOGY, 31